Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02402907 · ClinicalTrials.gov registry record · NA
STRIPES Study: Study To Reduce Infection Post cEsarean Section
A NA study, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- NA
- Development phase
- 1,356
- Enrollment target
NCT02402907: Completed NA study, sponsored by Icahn School of Medicine at Mount Sinai.
NCT02402907 is a NA study that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 1,356 participants, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02402907, a NA study, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,356 participants
- Enrollment target
Study Summary
The objective of this study is to determine if the use of chlorhexidine gluconate cloths prior to cesarean section reduce the rate of infectious morbidity (i.e. surgical site infections, endometritis). The study will be offered to women who present for a scheduled primary or repeat cesarean section at Mount Sinai Medical Center. The eligible women will be randomized to use of a 2% chlorhexidine gluconate (CHG) cloth or placebo cloth (a fragrance free cleansing cloth) the night before and the morning of their scheduled procedure. Participants will be blinded to the arm in which they have been assigned. This study intends to show that the use of 2% CHG cloths prior to cesarean section will reduce the rate of surgical site infections.
Primary Outcome
Number of participants with Incisional Surgical Site Infection (SSI)
Interventions
- DEVICE 2% chlorhexidine gluconate (CHG) cloth
- DEVICE Placebo cloth
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,356 participants |
| Start Date | 2015-04 |
| Est. Completion | 2019-10-11 |
| Phase | NA |
What the finished NCT02402907 record still lists
NCT02402907 is an interventional study that assigns participants to a tested intervention. Its 1,356 participants enrollment target places it among the larger protocols in the corpus, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target.
The record links to 0 conditions, and to 2 interventions - of which 2% chlorhexidine gluconate (CHG) cloth is the first listed.
NCT02402907 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02402907 about?
NCT02402907 is a clinical study titled "STRIPES Study: Study To Reduce Infection Post cEsarean Section". The objective of this study is to determine if the use of chlorhexidine gluconate cloths prior to cesarean section reduce the rate of infectious morbidity (i.e. surgical site infections, endometritis). The study will be offered to women who present for a scheduled primary or repeat cesarean section...
What is the current status of trial NCT02402907?
This trial is currently completed. It is a NA study. The enrollment target is 1,356 participants. The study started on 2015-04. Estimated completion is 2019-10-11.
What interventions are being tested in trial NCT02402907?
The interventions under investigation include: 2% chlorhexidine gluconate (CHG) cloth (DEVICE), Placebo cloth (DEVICE).
Who is sponsoring clinical trial NCT02402907?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02402907's enrollment target sits among peer trials
1,356 73rd of 2000 higher than 1,928 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05245227 · 1,358 participants · Phase 3
Double Simultaneous Uterotonic Agents Versus Single Agent Regimen to Prevent Early Postpartum Hemorrhage
- NCT06318169 · 1,350 participants · Phase 3
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
- NCT06605404 · 1,350 participants
Pan-tumor MRD Study
- NCT06806163 · 1,350 participants · NA
Machine-Learning Prediction and Reducing Overdoses With EHR Nudges
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia